Search

Bridget E. Bunner

Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1644, 1647
Total Applications
1463
Issued Applications
725
Pending Applications
157
Abandoned Applications
602

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6530067 [patent_doc_number] => 20100221217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'THERAPEUTIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/713497 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15026 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221217.pdf [firstpage_image] =>[orig_patent_app_number] => 12713497 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/713497
Therapeutic composition Feb 25, 2010 Issued
Array ( [id] => 9703930 [patent_doc_number] => 08828992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson\'s disease using the same' [patent_app_type] => utility [patent_app_number] => 13/202449 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29323 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202449 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/202449
Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same Feb 24, 2010 Issued
Array ( [id] => 7744400 [patent_doc_number] => 20120022046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections' [patent_app_type] => utility [patent_app_number] => 13/203351 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23959 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022046.pdf [firstpage_image] =>[orig_patent_app_number] => 13203351 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/203351
Thienopyridine derivatives for the treatment and prevention of dengue virus infections Feb 23, 2010 Issued
Array ( [id] => 6536886 [patent_doc_number] => 20100204214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/704460 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82087 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204214.pdf [firstpage_image] =>[orig_patent_app_number] => 12704460 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/704460
Histamine H3 inverse agonists and antagonists and methods of use thereof Feb 10, 2010 Issued
Array ( [id] => 6513841 [patent_doc_number] => 20100216699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/697967 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24191 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216699.pdf [firstpage_image] =>[orig_patent_app_number] => 12697967 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/697967
SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY Jan 31, 2010 Abandoned
Array ( [id] => 7487774 [patent_doc_number] => 20110251215 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-10-13 [patent_title] => 'MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/692078 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71724 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0251/20110251215.pdf [firstpage_image] =>[orig_patent_app_number] => 12692078 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/692078
Macrocyclic compounds and their use as kinase inhibitors Jan 21, 2010 Issued
Array ( [id] => 7487774 [patent_doc_number] => 20110251215 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-10-13 [patent_title] => 'MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/692078 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71724 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0251/20110251215.pdf [firstpage_image] =>[orig_patent_app_number] => 12692078 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/692078
Macrocyclic compounds and their use as kinase inhibitors Jan 21, 2010 Issued
Array ( [id] => 4451308 [patent_doc_number] => 07964632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Methods of treatment using a prodrug of an excitatory amino acid' [patent_app_type] => utility [patent_app_number] => 12/688074 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48965 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964632.pdf [firstpage_image] =>[orig_patent_app_number] => 12688074 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/688074
Methods of treatment using a prodrug of an excitatory amino acid Jan 14, 2010 Issued
Array ( [id] => 9503569 [patent_doc_number] => 08741883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Compounds and methods for the diagnosis and treatment of amyloid associated diseases' [patent_app_type] => utility [patent_app_number] => 12/687070 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20970 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12687070 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/687070
Compounds and methods for the diagnosis and treatment of amyloid associated diseases Jan 12, 2010 Issued
Array ( [id] => 6590629 [patent_doc_number] => 20100130482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/652512 [patent_app_country] => US [patent_app_date] => 2010-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12311 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130482.pdf [firstpage_image] =>[orig_patent_app_number] => 12652512 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/652512
DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS Jan 4, 2010 Abandoned
Array ( [id] => 10635592 [patent_doc_number] => 09353082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Pharmaceutical compounds' [patent_app_type] => utility [patent_app_number] => 13/141205 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 120788 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141205 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/141205
Pharmaceutical compounds Dec 22, 2009 Issued
Array ( [id] => 6637232 [patent_doc_number] => 20100173847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'TFPI INHIBITORS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/643818 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 179 [patent_figures_cnt] => 179 [patent_no_of_words] => 27620 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173847.pdf [firstpage_image] =>[orig_patent_app_number] => 12643818 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/643818
TFPI inhibitors and methods of use Dec 20, 2009 Issued
Array ( [id] => 7501752 [patent_doc_number] => 20110263608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => '16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/140625 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10651 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263608.pdf [firstpage_image] =>[orig_patent_app_number] => 13140625 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/140625
16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT Dec 20, 2009 Abandoned
Array ( [id] => 6428159 [patent_doc_number] => 20100168359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/640019 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11948 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168359.pdf [firstpage_image] =>[orig_patent_app_number] => 12640019 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/640019
Tri-functional UV-absorbing compounds and use thereof Dec 16, 2009 Issued
Array ( [id] => 7488467 [patent_doc_number] => 20110251384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'CYCLIC CARBODIIMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/139103 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13658 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251384.pdf [firstpage_image] =>[orig_patent_app_number] => 13139103 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/139103
Cyclic carbodiimide compounds Dec 14, 2009 Issued
Array ( [id] => 7501774 [patent_doc_number] => 20110263616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => '11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE MALEATE SALT' [patent_app_type] => utility [patent_app_number] => 13/133288 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6321 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263616.pdf [firstpage_image] =>[orig_patent_app_number] => 13133288 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133288
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt Dec 8, 2009 Issued
Array ( [id] => 7580889 [patent_doc_number] => 20110294772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS' [patent_app_type] => utility [patent_app_number] => 13/133939 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5305 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294772.pdf [firstpage_image] =>[orig_patent_app_number] => 13133939 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133939
USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS Dec 8, 2009 Abandoned
Array ( [id] => 7580948 [patent_doc_number] => 20110294831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE CITRATE SALT' [patent_app_type] => utility [patent_app_number] => 13/133297 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 6474 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294831.pdf [firstpage_image] =>[orig_patent_app_number] => 13133297 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133297
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt Dec 8, 2009 Issued
Array ( [id] => 8328698 [patent_doc_number] => 08236793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Diazabicyclic aryl derivatives as cholinergic receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/633505 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13359 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633505 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/633505
Diazabicyclic aryl derivatives as cholinergic receptor modulators Dec 7, 2009 Issued
Array ( [id] => 7670093 [patent_doc_number] => 20110319362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'STAT3 LIGANDS AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/128941 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20361 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128941 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/128941
STAT3 LIGANDS AND THERAPEUTIC USES THEREOF Dec 6, 2009 Abandoned
Menu